New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer

키워드

참고문헌 (100)

1. Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
2. Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer", N Engl J Med, 351, pp.1731~1740 (2004)
3. Gérard JP, "Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203", J Clin Oncol, 24, pp.4620~4625 (2006)
4. Roh MS, "Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03", J Clin Oncol, 27, pp.5124~5130 (2009)
5. Rödel C, "Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer", J Clin Oncol, 23, pp.8688~8696 (2005)
6. Eich HT, "Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression", Strahlenther Onkol, 187, pp.225~230 (2011)
7. Valentini V, "Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients", Int J Radiat Oncol Biol Phys, 53, pp.664~674 (2002)
8. Wheeler JM, "Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade", Dis Colon Rectum, 47, pp.2025~2031 (2004)
9. Habr-Gama A, "Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization", Dis Colon Rectum, 53, pp.1692~1698 (2010)
10. Smith JD, "Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy", Ann Surg, 256, pp.965~972 (2012)
11. Smith N, "Preoperative staging of rectal cancer", Acta Oncol, 47, pp.20~31 (2008)
12. van der Paardt MP, "Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging:a systematic review and meta-analysis", Radiology, 269, pp.101~112 (2013)
13. Dresen RC, "Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?", Radiology, 252, pp.71~80 (2009)
14. Barbaro B, "Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy", Radiology, 250, pp.730~739 (2009)
15. Curvo-Semedo L, "Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging", Radiology, 260, pp.734~743 (2011)
16. Ha HI, "Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy", Eur Radiol, 23, pp.3345~3353 (2013)
17. Kang JH, "Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response", Int J Radiat Oncol Biol Phys, 76, pp.1018~1025 (2010)
18. Yu SK, "MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?", Int J Radiat Oncol Biol Phys, 87, pp.505~511 (2013)
19. Chang GJ, "Rodriguez-Bigas MA, et al. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation", Dis Colon Rectum, 55, pp.371~377 (2012)
20. Sohn B, "MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer", Eur Radiol, 25, pp.1347~1355 (2015)
21. Padhani AR, "Multiparametric imaging of tumor response to therapy", Radiology, 256, pp.348~364 (2010)
22. Figueiras RG, "The role of functional imaging in colorectal cancer", AJR Am J Roentgenol, 195, pp.54~66 (2010)
23. Li SP, "Tumor response assessments with diffusion and perfusion MRI", J Magn Reson Imaging, 35, pp.745~763 (2012)
24. Leach MO, "The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations", Br J Cancer, 92, pp.1599~1610 (2005)
25. Gollub MJ, "Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer", Eur Radiol, 22, pp.821~831 (2012)
26. George ML, "Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer", Br J Surg, 88, pp.1628~1636 (2001)
27. Lim JS, "Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer", Eur Radiol, 22, pp.1693~1700 (2012)
28. Oberholzer K, "Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI", J Magn Reson Imaging, 38, pp.119~126 (2013)
29. Devries AF, "Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma", Cancer Res, 61, pp.2513~2516 (2001)
30. Kremser C, "Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis", J Magn Reson Imaging, 26, pp.662~671 (2007)
31. Lambregts DM, "Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study", Ann Surg Oncol, 18, pp.2224~2231 (2011)
32. Sun YS, "Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging", Radiology, 254, pp.170~178 (2010)
33. Ippolito D, "Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET", CT, 2012, pp.37, 1032~1040
34. Jung SH, "Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging", J Magn Reson Imaging, 35, pp.110~116 (2012)
35. Lambrecht M, "Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results", Int J Radiat Oncol Biol Phys, 82, pp.863~870 (2012)
36. Monguzzi L, "Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy", Eur J Radiol, 82, pp.234~240 (2013)
37. Intven M, "Diffusion-weighted MRI in locally advanced rectal cancer : pathological response prediction after neo-adjuvant radiochemotherapy", Strahlenther Onkol, 189, pp.117~122 (2013)
38. Barbaro B, "Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy", Int J Radiat Oncol Biol Phys, 83, pp.594~599 (2012)
39. Chennupati SK, "Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer", Am J Clin Oncol, 35, pp.334~339 (2012)
40. Hur H, "18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer", J Surg Oncol, 103, pp.17~24 (2011)
41. Amthauer H, "Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology", Eur J Nucl Med Mol Imaging, 31, pp.811~819 (2004)
42. Shanmugan S, "Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET", CT, 2012, pp.19, 2178~2185
43. Martoni AA, "Prospective study on the FDG-PET", CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer, 2011, pp.22, 650~656
44. Melton GB, "Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy", J Gastrointest Surg, 11, pp.961~969 (2007)
45. Kim JW, "Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy", Int J Colorectal Dis, 28, pp.1217~1224 (2013)
46. Maffione AM, "Fifteen different 18F-FDG PET", CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy, 2013, pp.40, 853~864
47. Capirci C, "The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery", Int J Radiat Oncol Biol Phys, 74, pp.1461~1469 (2009)
48. Janssen MH, "Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging", Int J Radiat Oncol Biol Phys, 77, pp.392~399 (2010)
49. Perez RO, "The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer", Dis Colon Rectum, 52, pp.1137~1143 (2009)
50. Kim CW, "Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection", Ann Surg Oncol, 18, pp.3271~3277 (2011)
51. Yang KL, "Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery", Radiat Oncol, 8, pp.43~ (2013)
52. Park JW, "Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery", Int J Radiat Oncol Biol Phys, 74, pp.810~817 (2009)
53. Lee JH, "Preoperative elevation of carcinoembryonic antigen predicts poor tumor response and frequent distant recurrence for patients with rectal cancer who receive preoperative chemoradiotherapy and total mesorectal excision: a multi-institutional analysis in an Asian population", Int J Colorectal Dis, 28, pp.511~517 (2013)
54. Jang NY, "The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer", Dis Colon Rectum, 54, pp.245~252 (2011)
55. Komuro Y, "Prediction of tumor radiosensitivity in rectal carcinoma based on p53 and Ku70 expression", J Exp Clin Cancer Res, 22, pp.223~228 (2003)
56. Fu CG, "Role of p53 and p21", WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients, 1998, pp.41, 68~74
57. Chen MB, "P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer", PLoS One, 7, pp.45388~ (2012)
58. Bertolini F, "Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy", Int J Radiat Oncol Biol Phys, 68, pp.1455~1461 (2007)
59. Lin LC, "p53and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy", Surg Oncol, 15, pp.211~216 (2006)
60. Spitz FR, "p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer", Clin Cancer Res, 3, pp.1685~1690 (1997)
61. Esposito G, "P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer", Ann Surg Oncol, 8, pp.311~318 (2001)
62. Hur H, "Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?", Dis Colon Rectum, 57, pp.592~601 (2014)
63. Charara M, "Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy", Anticancer Res, 24, pp.3161~3167 (2004)
64. Rau B, "Dynamic expression profile of p21WAF1", CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy, 2003, pp.21, 3391~3401
65. Reerink O, "Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy", Anticancer Res, 24, pp.1217~1221 (2004)
66. Kim NK, "p53, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancer", Ann Surg Oncol, 8, pp.418~424 (2001)
67. Jakob C, "Predictive value of Ki67 and p53 in locally advanced rectal cancer:correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy", World J Gastroenterol, 14, pp.1060~1066 (2008)
68. Rödel C, "Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer", Strahlenther Onkol, 176, pp.161~167 (2000)
69. Saw RP, "p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy", Dis Colon Rectum, 46, pp.192~202 (2003)
70. Chang HJ, "Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma", Hum Pathol, 36, pp.364~371 (2005)
71. Kudrimoti M, "Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers", J Ky Med Assoc, 105, pp.18~22 (2007)
72. Sarela AI, "Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas", Ann Surg Oncol, 8, pp.305~310 (2001)
73. Zlobec I, "Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy", Br J Cancer, 98, pp.450~456 (2008)
74. Qiu H, "Molecular prognostic factors in rectal cancer treated by radiation and surgery", Dis Colon Rectum, 43, pp.451~459 (2000)
75. Smith FM, "COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy", Int J Radiat Oncol Biol Phys, 64, pp.466~472 (2006)
76. Min BS, "Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer", Arch Surg, 143, pp.1091~1097 (2008)
77. Giralt J, "Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy", Int J Radiat Oncol Biol Phys, 54, pp.1460~1465 (2002)
78. Kim JS, "Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy", Int J Radiat Oncol Biol Phys, 66, pp.195~200 (2006)
79. Spindler KL, "Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors", Dis Colon Rectum, 50, pp.1363~1369 (2007)
80. Okonkwo A, "Molecular markers and prediction of response to chemoradiation in rectal cancer", Oncol Rep, 8, pp.497~500 (2001)
81. Negri FV, "Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy", Br J Cancer, 98, pp.143~147 (2008)
82. Hur H, "Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer", Int J Radiat Oncol Biol Phys, 81, pp.669~676 (2011)
83. Sprenger T, "Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival", Cancer, 119, pp.26~35 (2013)
84. Huh JW, "Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer", Ann Surg, 259, pp.508~515 (2014)
85. Nishioka M, "Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer", Cancer Genomics Proteomics, 8, pp.87~92 (2011)
86. Rimkus C, "Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer", Clin Gastroenterol Hepatol, 6, pp.53~61 (2008)
87. Ghadimi BM, "Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy", J Clin Oncol, 23, pp.1826~1838 (2005)
88. Watanabe T, "Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles", Cancer Res, 66, pp.3370~3374 (2006)
89. Watanabe T, "Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes", Dis Colon Rectum, 57, pp.23~31 (2014)
90. Kim JC, "Novel single-nucleotide polymorphism markers predictive of pathologic response to preoperative chemoradiation therapy in rectal cancer patients", Int J Radiat Oncol Biol Phys, 86, pp.350~357 (2013)
91. Havelund BM, "Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer", APMIS, 121, pp.127~138 (2013)
92. Supiot S, "Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study", World J Gastroenterol, 19, pp.3249~3254 (2013)
93. van Stiphout RG, "Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: a multicentric prospective study with external validation", Radiother Oncol, 113, pp.215~222 (2014)
94. Lambrecht M, "The use of FDG-PET", CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer, 2010, pp.49, 956~963
95. Maas M, "Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer", J Clin Oncol, 29, pp.4633~4640 (2011)
96. Keam B, "Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy", J Cancer Res Clin Oncol, 137, pp.1301~1308 (2011)
97. Jwa E, "Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer", Br J Cancer, 111, pp.249~254 (2014)
98. Chau I, "Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer", J Clin Oncol, 24, pp.668~674 (2006)
99. Maréchal R, "Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study", Ann Oncol, 23, pp.1525~1530 (2012)
100. Cercek A, "Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer", J Natl Compr Canc Netw, 12, pp.513~519 (2014)

관련 논문AI추천